Anti-Tumor and Anti-Inflammatory Activity In Vivo of Cogn. (Cucurbitaceae)
Overview
Authors
Affiliations
This work aimed to carry out a study of by investigating its chemical composition and pharmacological potential. From the dichloromethane phase (Dic-Ac) of the stems, three compounds were identified: cayaponoside C (Ac-1), cabenoside C (Ac-2) and fevicordin C glucoside (Ac-3), being last identified for the first time as a natural product. These compounds were obtained by chromatographic methods and their structures were elucidated by means of spectroscopic analysis of IR, MS and NMR. In the quantification of Dic-Ac, it was possible to observe the presence of 7% of cayaponoside C. Dic-Ac showed significant toxicity for in vivo tests, with macroscopic and biochemical changes. The anti-inflammatory activity of Dic-Ac was investigated using the paw edema model. A decrease in inflammatory signs was observed in the first 5 h and the most effective dose in reducing edema with was 7.5 mg kg (66.6%). Anti-tumor activity of Dic-Ac was evaluated by Ehrlich's carcinoma model, which showed inhibition rate of 78.46% at 15 mg kg dosage. The phytochemical investigation, together with the biological tests carried out in this study, demonstrated that is a promising species in the search for therapeutics, since it contains substances with high pharmacological potential in its composition.
(Cucurbitaceae) Shows Strong Anti-Inflammatory Activity in Murine Models of Acute Inflammation.
Andrade M, Marinho P, Macario de Oliveira A, de Souza T, Cibulski S, da Silva Alves H Pharmaceutics. 2024; 16(10).
PMID: 39458627 PMC: 11510368. DOI: 10.3390/pharmaceutics16101298.
Xanthine Oxidase Inhibitory Activity and Chemical Composition of Leaf Essential Oil.
Huang C, Chang Y, Chang S, Chang H Pharmaceutics. 2022; 14(10).
PMID: 36297418 PMC: 9609098. DOI: 10.3390/pharmaceutics14101982.
Antifungal Sesquiterpenoids from Leaf Essential Oil against Wood-Rotting Fungi.
Wu C, Huang S, Ko C, Chang H Molecules. 2022; 27(7).
PMID: 35408536 PMC: 9000555. DOI: 10.3390/molecules27072136.
Chen G, Chang M, Chang S, Ho Y, Chang H Pharmaceutics. 2022; 14(2).
PMID: 35214084 PMC: 8880271. DOI: 10.3390/pharmaceutics14020351.
Huang C, Liu I, Huang X, Chen H, Chang S, Chang M Pharmaceutics. 2021; 13(7).
PMID: 34371750 PMC: 8309042. DOI: 10.3390/pharmaceutics13071059.